RESUMO
Vitamin C was reported to be able to protect against oxidative damage due to its reducibility. 120 Wistar rats were randomly divided into 4 × 2 groups, including normal iodine (NI), high iodine (HI), low vitamin C (HI + LC), and high vitamin C (HI + HC); potassium iodide (KI) and potassium iodate (KIO3) were commonly used as additives for iodized salt, so every group was also divided into KI and KIO3 groups. After 6 months' feed, the activities of antioxidant enzymes and Lipid Peroxide (MDA) content in serum, liver, kidney, brain, thyroid and lens were determined. In serum, for males, long-term excess iodine intake caused oxidative damage; in the liver, male rats in the HI + LC group had the highest MDA content, which showed that low-dose vitamin C might promote oxidative damage; in kidneys, the MDA content in the HI and HI + LC groups of females was higher; in the brain, high-dose vitamin C could increase the activity of superoxide dismutase (SOD), which was decreased by high iodine intake, and it also decreased MDA content; in the thyroid, for KIO3, the activity of SOD in the HI group was lower than NI and HI + LC; in the lens, the MDA content in females was lower than males. Long-term excess iodine exposure caused oxidative damage and showed sex difference, and vitamin C had a protective effect on it, especially for high-dose vitamin C.
Assuntos
Ácido Ascórbico , Iodo , Vitaminas , Animais , Feminino , Masculino , Ratos , Antioxidantes/metabolismo , Ácido Ascórbico/farmacologia , Iodo/efeitos adversos , Estresse Oxidativo , Iodeto de Potássio/efeitos adversos , Ratos Wistar , Superóxido Dismutase/metabolismo , Vitaminas/farmacologiaRESUMO
BACKGROUND: Cutaneous sporotrichosis, a subcutaneous mycosis because of Sporothrix schenckii, is sporadic worldwide with local hyperendemic pockets. OBJECTIVES: To study clinico-epidemiological and therapeutic aspects of sporotrichosis in our clinic. METHODS: We retrospectively analyzed medical records of 152 (M:F 52:100) patients with cutaneous sporotrichosis managed during 2010-2019. RESULTS: All patients were involved in agricultural activities, and 63.2% were aged 21-60 years. Women outnumbered men by nearly two times. Fixed and lymphocutaneous sporotrichosis occurred in 54.6% and 43.4% patients, respectively. Only 2% of patients had multifocal sporotrichosis. Only 48% of patients imputed their disease to prior injuries. Extremities, upper in 53.9% and lower in 21% of patients, were mostly involved. Scrotum involvement in one patient was unusual. A mixed inflammatory infiltrate in 38.7%, chronic granuloma formation in 35%, and presence of spores in 48.9% biopsies was noted. S. schenckii grew on Sabouraud's dextrose agar in 40.2% of cases. Treatment with saturated solution of potassium iodide was curative in 76.8% patients, and lesions healed in 2-9 months (average 5.2 months). Metallic taste was experienced by 42.9% of patients. Itraconazole therapy was safe and effective in seven patients, and the response was better when combined with SSKI compared to either drug used alone. CONCLUSION: Cutaneous sporotrichosis mostly affects persons during active years of life. The injuries predisposing to infection are mostly forgotten. Both fixed and lymphocutaneous sporotrichosis involving extremities remain common forms. SSKI alone or in combination with itraconazole is safe and effective treatment. Itraconazole is preferable in patients having preexisting hypothyroidism or intolerance to SSKI.
Assuntos
Agricultura , Antifúngicos/uso terapêutico , Granuloma/microbiologia , Doenças Profissionais/tratamento farmacológico , Iodeto de Potássio/uso terapêutico , Esporotricose/tratamento farmacológico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Antifúngicos/efeitos adversos , Criança , Tratamento Farmacológico , Extremidades , Feminino , Humanos , Índia/epidemiologia , Itraconazol/uso terapêutico , Masculino , Pessoa de Meia-Idade , Doenças Profissionais/epidemiologia , Doenças Profissionais/etiologia , Doenças Profissionais/patologia , Iodeto de Potássio/efeitos adversos , Estudos Retrospectivos , Esporos Fúngicos , Esporotricose/epidemiologia , Esporotricose/etiologia , Esporotricose/patologia , Ferimentos e Lesões/complicações , Adulto JovemRESUMO
BACKGROUND: Potassium iodide (KI) treatment affects the vascularity of the thyroid gland and therefore may improve intraoperative visualization of essential structures. However, clear evidence for its usage is lacking, and its implementation in patients suffering from Graves' disease is becoming rare. The objective of this retrospective study was to assess the impact of KI treatment on the intraoperative course and the outcome of patients undergoing thyroidectomy for Graves' diseases. METHODS: The study included 442 patients: 125 patients (28.3%) who received a preoperative treatment with KI ("Group KI") and 317 patients (71.7%) without a KI therapy ("Group No-KI"). Indication for KI treatment was a thyroid bruit (82.5%), as well as hyperthyroidism refractive to medical treatment with antithyroid drugs (17.4%). RESULTS: All patients underwent total thyroidectomy. Permanent vocal cord paresis and permanent hypoparathyroidism were similar in both groups. KI treatment was associated with a significantly longer operative time (142 vs. 128 min, p < 0.001) and a significant higher weight of the thyroid gland. KI treatment did not impact duration of hospital stay or occurrence of secondary hemorrhage. CONCLUSIONS: The complication rate of this study population with clinically severe GD was very low-which may be caused by pre-treatment of patients. The complementary option of a potassium iodide treatment before surgery remains a possibility and should be implemented individually.
Assuntos
Doença de Graves/cirurgia , Iodeto de Potássio/administração & dosagem , Tireoidectomia , Adolescente , Adulto , Distribuição por Idade , Idoso , Idoso de 80 Anos ou mais , Criança , Feminino , Doença de Graves/tratamento farmacológico , Humanos , Hipoparatireoidismo/etiologia , Masculino , Pessoa de Meia-Idade , Duração da Cirurgia , Complicações Pós-Operatórias , Iodeto de Potássio/efeitos adversos , Cuidados Pré-Operatórios , Estudos Retrospectivos , Tireoidectomia/efeitos adversos , Resultado do Tratamento , Paralisia das Pregas Vocais/etiologia , Adulto JovemRESUMO
BACKGROUND: Concern that mild iodine deficiency in pregnancy may adversely affect neurodevelopment of offspring has led to recommendations for iodine supplementation in the absence of evidence from randomised controlled trials. The primary objective of the study was to investigate the effect of iodine supplementation during pregnancy on childhood neurodevelopment. Secondary outcomes included pregnancy outcomes, maternal thyroid function and general health. METHODS: Women with a singleton pregnancy of fewer than 20 weeks were randomly assigned to iodine (150 µg/d) or placebo from trial entry to birth. Childhood neurodevelopment was assessed at 18 months by using Bayley Scales of Infant and Toddler Development (Bayley-III). Iodine status and thyroid function were assessed at baseline and at 36 weeks' gestation. Pregnancy outcomes were collected from medical records. RESULTS: The trial was stopped after 59 women were randomly assigned following withdrawal of support by the funding body. There were no differences in childhood neurodevelopmental scores between the iodine treated and placebo groups. The mean cognitive, language and motor scores on the Bayley-III (iodine versus placebo, respectively) were 99.4 ± 12.2 versus 101.7 ± 8.2 (mean difference (MD) -2.3, 95 % confidence interval (CI) -7.8, 3.2; P = 0.42), 97.2 ± 12.2 versus 97.9 ± 11.5 (MD -0.7, 95 % CI -7.0, 5.6; P = 0.83) and 93.9 ± 10.8 versus 92.4 ± 9.7 (MD 1.4, 95 % CI -4.0, 6.9; P = 0.61), respectively. No differences were identified between groups in any secondary outcomes. CONCLUSIONS: Iodine supplementation in pregnancy did not result in better childhood neurodevelopment in this small trial. Adequately powered randomised controlled trials are needed to provide conclusive evidence regarding the effect of iodine supplementation in pregnancy. TRIALS REGISTRATION: The trial was registered with the Australian New Zealand Clinical Trials Registry at http://www.anzctr.org.au . The registration number of this trial is ACTRN12610000411044 . The trial was registered on 21 May 2010.
Assuntos
Desenvolvimento Infantil/efeitos dos fármacos , Suplementos Nutricionais , Saúde Materna , Sistema Nervoso/efeitos dos fármacos , Iodeto de Potássio/administração & dosagem , Complicações na Gravidez/prevenção & controle , Cuidado Pré-Natal/métodos , Glândula Tireoide/efeitos dos fármacos , Adulto , Fatores Etários , Austrália , Linguagem Infantil , Cognição/efeitos dos fármacos , Suplementos Nutricionais/efeitos adversos , Método Duplo-Cego , Término Precoce de Ensaios Clínicos , Feminino , Humanos , Lactente , Masculino , Atividade Motora/efeitos dos fármacos , Sistema Nervoso/crescimento & desenvolvimento , Testes Neuropsicológicos , Nova Zelândia , Iodeto de Potássio/efeitos adversos , Gravidez , Complicações na Gravidez/diagnóstico , Complicações na Gravidez/fisiopatologia , Projetos de Pesquisa , Testes de Função Tireóidea , Glândula Tireoide/fisiopatologia , Fatores de Tempo , Resultado do Tratamento , Adulto JovemRESUMO
PURPOSE: Iodine, bivalent iron (Fe²âº), and hydrogen peroxide (H2O2), all significantly affecting the red-ox balance, are required for thyroid hormone synthesis. Intracellular iodine excess (≥10⻳ M) transiently blocks thyroid hormonogenesis (an adaptive mechanism called Wolff-Chaikoff effect). The aim of the study was to evaluate the effects of iodine, used as potassium iodide (KI) or potassium iodate (KIO3), in concentrations corresponding to those typical for Wolff-Chaikoff effect, on the level of oxidative damage to nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) isolated from porcine thyroid under basal conditions and in the presence of Fenton reaction (Fe²âº+H2O2 â Fe³âº+(·)OH + OHâ») substrates. METHODS: Thyroid nDNA and mtDNA were incubated in the presence of either KI or KIO3 (2.5-50 mM), without/with FeSO4 (30 µM) + H2O2 (0.5 mM). Index of DNA damage, i.e., 8-oxo-7,8-dihydro-2'-deoxyguanosine, was measured by HPLC. RESULTS: Neither KI nor KIO3 increased the basal level of 8-oxodG in both nDNA and mtDNA. KI-in all used concentrations-completely prevented the damaging effect of Fenton reaction substrates in mtDNA, and it partially prevented this damage in nDNA. KIO3 partially prevented Fe²âº+H2O2-induced oxidative damage in both DNA only in its highest used concentrations (≥25 mM). CONCLUSIONS: Without additional prooxidative abuse, both iodine compounds, i.e., KI and KIO3, seem to be safe in terms of their potential oxidative damage to DNA in the thyroid. The superiority of KI over KIO3 relies on its stronger protective effects against oxidative damage to mtDNA, which constitutes an argument for its preferential utility in iodine prophylaxis.
Assuntos
Dano ao DNA , DNA Mitocondrial/química , Suplementos Nutricionais , Oxidantes/antagonistas & inibidores , Iodeto de Potássio/química , Substâncias Protetoras/química , 8-Hidroxi-2'-Desoxiguanosina , Matadouros , Animais , DNA/química , DNA/efeitos dos fármacos , DNA/isolamento & purificação , DNA Mitocondrial/efeitos dos fármacos , DNA Mitocondrial/isolamento & purificação , Desoxiguanosina/análogos & derivados , Desoxiguanosina/análise , Suplementos Nutricionais/efeitos adversos , Alimentos Fortificados , Peróxido de Hidrogênio/antagonistas & inibidores , Peróxido de Hidrogênio/toxicidade , Iodatos/efeitos adversos , Iodatos/química , Ferro/toxicidade , Concentração Osmolar , Oxidantes/toxicidade , Oxirredução , Compostos de Potássio/efeitos adversos , Compostos de Potássio/química , Iodeto de Potássio/efeitos adversos , Substâncias Protetoras/efeitos adversos , Sus scrofa , Glândula Tireoide/químicaRESUMO
OBJECTIVE: Excessive iodine ingestion may cause thyroid dysfunction. In this case series, we report four patients who developed significant thyroid dysfunction after ingesting over-the-counter (OTC) drugs containing large concentrations of iodine. METHODS: Four patients from a tertiary medical center are reported. RESULTS: Case 1 involved acute exacerbation of thyrotoxicosis induced by taking OTC Tri-iodine™ in a 35-year-old woman while still on methimazole therapy. Case 2 involved thyroid-extract-induced thyrotoxicosis following ingestion of Thyromine™, and was confirmed by laboratory studies and ¹³¹I thyroid uptake. Cases 3 and 4 involved severe, symptomatic hypothyroidism induced in 2 patients with underlying autoimmune thyroiditis (Hashimoto's disease) following ingestion of Iodoral™. In all cases, thyroid dysfunction resolved with appropriate management and discontinuation of the OTC drugs. CONCLUSION: These case reports demonstrate the significant risks associated with OTC preparations containing iodine in patients predisposed to thyroid dysfunction. There is no valid reason for taking high-dose OTC iodine supplements, which have been shown to cause harm and have no known benefit.
Assuntos
Suplementos Nutricionais/efeitos adversos , Iodo/intoxicação , Doenças da Glândula Tireoide/etiologia , Glândula Tireoide/fisiopatologia , Adulto , Feminino , Humanos , Hipotireoidismo/sangue , Hipotireoidismo/etiologia , Hipotireoidismo/fisiopatologia , Hipotireoidismo/terapia , Iodo/sangue , Maryland , Pessoa de Meia-Idade , Iodeto de Potássio/efeitos adversos , Tireoide (USP)/efeitos adversos , Doenças da Glândula Tireoide/sangue , Doenças da Glândula Tireoide/fisiopatologia , Doenças da Glândula Tireoide/terapia , Tireotoxicose/sangue , Tireotoxicose/etiologia , Tireotoxicose/fisiopatologia , Tireotoxicose/terapia , Resultado do TratamentoRESUMO
PURPOSE: The aim of the present feeding trial with iodine was to assess pigs' growth performance and carcass characteristics, the iodine accumulation in tissues, and their influences on the thyroid hormones in plasma. METHODS: Eighty pigs (33-115 kg body weight) were allotted to 5 dietary treatments: a control group (150 µg I/kg), two potassium iodide [KI] groups (4,000 and 10,000 µg I/kg), and two potassium iodate [KIO3] groups (4,000 and 10,000 µg I/kg). Iodine concentration was determined in thyroid gland, liver, kidney, muscle, fat, and skin by ICP-MS. Furthermore, thyroxine (T4) and triiodothyronine (T3) in plasma were evaluated. RESULTS: High dietary iodine tended to have a negative effect on younger animals' growth (average daily gain, ADG). However, during the entire growth period, the growth performance and carcass characteristics were not influenced by iodine dosages or sources. Irrespective of iodine source, higher iodine doses of diets affected higher iodine stores in all tested tissues except for abdominal fat. Thus, iodine supplementation with 10,000 µg I/kg feed significantly increased iodine content in thyroid gland (+122%), liver (+260%), kidney (+522%), muscle (+131%), and skin (+321%) compared to the control group. However, there was no significance of thyroid hormones in plasma. CONCLUSIONS: As a result, pork and fat of pigs showed only low iodine accumulation even in the high-iodine groups. Thus, there should be no risk of an iodine excess in human nutrition and animal health, and the EU-upper level for iodine in pig feed can be maintained.
Assuntos
Criação de Animais Domésticos , Dieta/veterinária , Iodo/administração & dosagem , Carne/análise , Sus scrofa/crescimento & desenvolvimento , Sus scrofa/metabolismo , Hormônios Tireóideos/sangue , Animais , Áustria , Cruzamentos Genéticos , Dieta/efeitos adversos , Ingestão de Energia , Iodatos/administração & dosagem , Iodatos/efeitos adversos , Iodatos/uso terapêutico , Iodo/efeitos adversos , Iodo/deficiência , Iodo/uso terapêutico , Rim/crescimento & desenvolvimento , Rim/metabolismo , Fígado/crescimento & desenvolvimento , Fígado/metabolismo , Masculino , Especificidade de Órgãos , Compostos de Potássio/administração & dosagem , Compostos de Potássio/efeitos adversos , Compostos de Potássio/uso terapêutico , Iodeto de Potássio/administração & dosagem , Iodeto de Potássio/efeitos adversos , Iodeto de Potássio/uso terapêutico , Pele/crescimento & desenvolvimento , Pele/metabolismo , Sus scrofa/sangue , Tiroxina/sangue , Tri-Iodotironina/sangue , Aumento de PesoRESUMO
Relation between iodine (I) intake by lactating Holstein cows and iodine concentrations in raw and pasteurized milk were investigated. Four treatment groups with eight cows assigned to each treatment were fed a basal diet containing 0.534 mg I/kg alone or supplemented with potassium iodide at 2.5, 5 or 7.5 mg/kg in 7-week period. Iodine concentrations in raw milk increased with each increase in dietary I from 162.2 ng/ml for basal diet to 534.5, 559.8 and 607.5 ng/ml when 2.5, 5 and 7.5 mg/kg was fed as potassium iodide (P < 0.05). This trend was found for blood plasma and urine iodine concentration. Iodine supplementation had no significant effect on thyroidal hormones. high-temperature short-time (HTST) pasteurization process reduced I concentration. The mean iodine content found in the milk prior to heating processing was 466.0 ± 205.0 ng/ml, whereas for the processed milk this level was 349.5 ± 172.8 ng/ml. It was concluded that iodine supplementation above of NRC recommendation (0.5 mg/kg diet DM) resulted in significant increases in iodine concentrations in milk, although the effect of heating in HTST pasteurization process on iodine concentration was not negligible.
Assuntos
Iodo/química , Leite/química , Iodeto de Potássio/administração & dosagem , Animais , Bovinos , Suplementos Nutricionais , Calefação , Iodo/análise , Iodeto de Potássio/efeitos adversosRESUMO
OBJECTIVE: Combined treatment with anti-thyroid drugs (ATDs) and potassium iodide (KI) has been used only for severe thyrotoxicosis or as a pretreatment before urgent thyroidectomy in patients with Graves' disease. We compared methimazole (MMI) treatment with MMI + KI treatment in terms of rapid normalization of thyroid hormones during the early phase and examined the later induction of disease remission. DESIGN AND PATIENTS: A total of 134 untreated patients with Graves' disease were randomly assigned to one of four regimens: Group 1, MMI 30 mg; Group 2, MMI 30 mg + KI; Group 3, MMI 15 mg and Group 4, MMI 15 mg + KI. For easy handling, KI tablets were used instead of saturated solution of KI. KI was discontinued when patients showed normal free thyroxine (FT4) levels but MMI was continued with a tapering dosage until remission. Remission rate was examined during a 4- to 5-year observation. MEASUREMENTS: Serum FT4, FT3 and TSH were measured by chemiluminescent immunoassays. TSH receptor antibody (TRAb) was assayed with TRAb-ELISA. Goitre size was estimated by ultrasonography. RESULTS: After 2 weeks of treatment, normal FT4 was observed in 29% of patients in Group 1 and 59% (P < 0.05) of patients in Group 2. Furthermore, normal FT4 after 2 weeks of treatment was observed in 27% of patients in Group 3 and 54% (P < 0.05) of patients in Group 4. Similarly, FT3 normalized more rapidly in Groups 2 and 4 than in Groups 1 and 3. None of the patients showed an increase in thyroid hormones or aggravation of disease during combined treatment with MMI and KI. The remission rates in Groups 1, 2, 3 and 4 were 34%, 44%, 33% and 51%, respectively, and were higher in the groups receiving combined therapy but differences among four groups did not reach significance. CONCLUSIONS: Combined treatment with MMI and KI improved the short-term control of Graves' hyperthyroidism and was not associated with worsening hyperthyroidism or induction of thionamide resistance.
Assuntos
Antitireóideos/administração & dosagem , Doença de Graves/tratamento farmacológico , Iodeto de Potássio/administração & dosagem , Tireotoxicose/tratamento farmacológico , Adulto , Antitireóideos/efeitos adversos , Esquema de Medicação , Quimioterapia Combinada , Feminino , Doença de Graves/sangue , Doença de Graves/complicações , Humanos , Masculino , Metimazol/administração & dosagem , Metimazol/efeitos adversos , Pessoa de Meia-Idade , Iodeto de Potássio/efeitos adversos , Indução de Remissão , Medição de Risco , Testes de Função Tireóidea , Hormônios Tireóideos/sangue , Tireotoxicose/sangue , Tireotoxicose/etiologia , Fatores de Tempo , Resultado do Tratamento , Adulto JovemRESUMO
Sporotrichosis is a chronic infectious granuloma of skin. The detection of fungal elements in pathological examination and the isolation of Sporothrix schenckii from the lesion are requisite for diagnosis. The sporotrichin test is useful as an auxiliary examination, but a false-negative reaction might occur in some cases. Oral potassium iodide is first choice of treatment, because of its modest cost and usefulness, although gastrointestinal disorder is a frequent side effect. Itraconazole should be the second selection, and then terbinafine. Local thermotherapy is also effective as an additional therapy. Dematiaceous fungal skin infections are divided into two groups by their parasitic form, chromoblastomycosis and phaeohyphomycosis. Chromoblastomycosis is also called chromomycosis in Japan. It is most important for clinical diagnosis to detect dark brown spores in the scale of chromoblastomycosis and dark brown hyphae in the pus of phaeohyphomycosis by microscopic examination. Both morphological and molecular biological approaches are recommended for identification of fungi. In treatment, the drug appropriate in each case should be selected, and the combination of surgical excision, local thermotherapy, laser therapy or cryotherapy must be considered.
Assuntos
Cromoblastomicose/diagnóstico , Cromoblastomicose/terapia , Esporotricose/diagnóstico , Esporotricose/terapia , Administração Oral , Cromoblastomicose/microbiologia , Terapia Combinada , Gastroenteropatias/induzido quimicamente , Humanos , Itraconazol/uso terapêutico , Microscopia , Naftalenos/uso terapêutico , Iodeto de Potássio/administração & dosagem , Iodeto de Potássio/efeitos adversos , Sporothrix/isolamento & purificação , Sporothrix/ultraestrutura , Esporotricose/microbiologia , Esporotricose/patologia , TerbinafinaRESUMO
It has generally been thought that iodine allergy is cross-sensitive to various iodine-containing chemicals. However, this concept seems to deviate from the immunological principle that immune recognition is specific. To solve this contradiction, we hypothesize that iodine allergy is an immunological reaction to iodinated autologous proteins produced in vivo by iodination reaction from various iodine-containing chemicals. Antisera to iodine were obtained from guinea pigs immunized subcutaneously with iodine-potassium iodide solution emulsified in complete Freund's adjuvant (CFA). The specificity of guinea pig anti-iodine antiserum was determined by enzyme-linked immunosorbent assay (ELISA) inhibition experiments using microplates coated with iodinated guinea pig serum albumin (I-GSA). Antibody activities were inhibited by I-GSA, diiodo-L-tyrosine, and thyroxine, but not by potassium iodide, monoiodo-L-tyrosine, 3,5,3'-triiodothyronine, monoiodo-L-histidine, or diiodo-L-histidine, or by ionic or non-ionic iodinated contrast media. The results that antigen recognition of anti-iodine antibody is specific to iodinated protein support our hypothesis. While protein iodination usually takes place both at histidine residues as well as at tyrosine residues, only iodinated tyrosine acted as an antigenic determinant and no antibody activities to iodinated histidine were detected in our experimental iodine allergy model.
Assuntos
Reações Antígeno-Anticorpo/imunologia , Antígenos/imunologia , Epitopos/imunologia , Hipersensibilidade/imunologia , Iodeto de Potássio/imunologia , Animais , Especificidade de Anticorpos , Antígenos/análise , Sítios de Ligação de Anticorpos , Reações Cruzadas , Di-Iodotirosina/efeitos adversos , Di-Iodotirosina/imunologia , Modelos Animais de Doenças , Relação Dose-Resposta Imunológica , Ensaio de Imunoadsorção Enzimática/métodos , Feminino , Adjuvante de Freund , Cobaias , Iodeto de Potássio/efeitos adversos , Albumina Sérica/imunologia , Tiroxina/efeitos adversos , Tiroxina/imunologiaRESUMO
Sporotrichosis is a chronic fungal infection that most commonly involves the skin and lymphatics. It is classified into five forms: classic lymphocutaneous, fixed cutaneous, disseminated cutaneous, primary pulmonary, and systemic sporotrichosis. Its diagnosis is established by fungal culture or by direct immunofluorescence. Safe effective therapy for cutaneous sporotrichosis exists in the form of oral potassium iodide and local heat therapy. However, itraconazole, one of the newer triazole antimycotic agents, appears quite effective against Sporothrix schenckii and may provide a means of reducing both the length of therapy and the relapse rate. Systemic sporotrichosis, although still rare, is becoming more common, especially in immunosuppressed patients. Because of multisystem involvement, both diagnosis and management of patients with systemic sporotrichosis are difficult. Serologic antibody tests such as the slide latex agglutination test are useful to confirm the diagnosis and to determine the effectiveness of antifungal therapy. Intravenous amphotericin B is still considered the drug of choice for systemic sporotrichosis, but the search for a less toxic agent continues. Also, combination drug therapy and surgical intervention are necessary for some patients with extracutaneous sporotrichosis.
Assuntos
Esporotricose , Administração Oral , Adulto , Fatores Etários , Criança , Dermatomicoses/patologia , Diagnóstico Diferencial , Surtos de Doenças/prevenção & controle , Feminino , Imunofluorescência , História do Século XIX , História do Século XX , Humanos , Iodetos/administração & dosagem , Iodetos/uso terapêutico , Masculino , Iodeto de Potássio/administração & dosagem , Iodeto de Potássio/efeitos adversos , Fatores Sexuais , Esporotricose/tratamento farmacológico , Esporotricose/epidemiologia , Esporotricose/história , Ferimentos Penetrantes/microbiologiaRESUMO
In sixteen cases of toxic adenoma of the thyroid (autonomous hot nodule with complete suppression of the surrounding normal parenchyma) potassium iodide was given in doses of 100 microgram/day for one week, 200 microgram/day for another and 400 microgram/day for a third week. There was a progressive increase in the serum T4 level. Serum T3 also increased, although this was significant only after the first week. Serum TSH was undetectable throughout the entire period of the study. This metabolic pattern is different from the response seen in cases of nontoxic endemic goitre, where small iodine supplements induce an increase in serum T4 but a decrease in serum T3. Furthermore, the present results may explain the phenomenon of iodine-induced or iodine-precipitated hyperthyroidism (Jod-Basedow) when patients with autonomous thyroid are presented with a high iodine intake. In contrast to the results obtained with small iodide doses, two other cases treated with large pharmacological doses of iodide showed a decrease in both serum T4 and serum T3. It is concluded that the physician should be aware of the possibility of precipitating or aggravating thyrotoxicosis in patients with an autonomous hot nodule by increasing their intake of iodine.